CELLI FRANK E. 4
4 · BIOHITECH GLOBAL, INC. · Filed May 25, 2018
Insider Transaction Report
Form 4
CELLI FRANK E.
DirectorChairman and CEO
Transactions
- Conversion
Common Stock, par value $0.0001
2018-05-24$2.75/sh+163,637$450,002→ 1,457,322 total - Conversion
Convertible Promissory Note
2018-05-24$450000.00/sh−1$450,000→ 0 totalExercise: $2.75From: 2017-05-24Exp: 2018-05-24→ Common Stock (163,637 underlying) - Conversion
Convertible Promissory Note
2018-05-24$450000.00/sh−1$450,000→ 0 total(indirect: By Trust)Exercise: $2.75From: 2017-01-13Exp: 2018-05-24→ Common Stock (163,638 underlying) - Conversion
Common Stock, par value $0.0001
2018-05-24$4.30/sh+3,205$13,782→ 1,460,527 total - Conversion
Common Stock, par value $0.0001
2018-05-24$4.30/sh+10,063$43,271→ 925,484 total(indirect: By Trust) - Conversion
Common Stock, par value $0.0001
2018-05-24$2.75/sh+163,638$450,005→ 915,421 total(indirect: By Trust)
Footnotes (6)
- [F1]163,637 shares at $2.75 per share represent the conversion at maturity of a convertible note initially entered into on May 24, 2017.
- [F2]3,205 shares at $4.30 per share represent the payment of interest at 3.5% on the note.
- [F3]Does not include 1,460,527 shares of common stock held by reporting person.
- [F4]Frank E. Celli holds voting and dispositive control over the Frank E. Celli Family Trust.
- [F5]163,638 shares at $2.75 per share represent the conversion at maturity of a convertible note initially entered into on January 13, 2017.
- [F6]10,063 shares at $4.30 per share represent the payment of interest at 8% on the note.